{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:44:39Z","timestamp":1787316279385,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFD1801103-6"],"award-info":[{"award-number":["2021YFD1801103-6"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 31972719"],"award-info":[{"award-number":["No. 31972719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    Nipah virus (NiV) is a newly emerged extremely dangerous zoonotic pathogen highly fatal to humans. Currently, no approved vaccine is available against NiV. This study employed a mammalian eukaryotic system to express NiV soluble G glycoprotein (NiV-sG), using CpG oligodeoxynucleotides (CpG)\/Aluminum salt (Alum) as adjuvants to obtain a recombinant subunit vaccine candidate. We also evaluated the immunogenicity and efficacy of the protein in mice and pigs. The results showed that humoral and cellular immune responses were induced in all the vaccination groups in two animal models. The levels of specific and neutralizing antibodies and the proliferation levels of T helper(Th) cells were significantly higher than those in the control group. The protective efficacy of the subunit vaccines evaluated in the pseudovirus\n                    <jats:italic>in vivo<\/jats:italic>\n                    infection mouse model strongly suggested that this vaccine could provide protective immunity against NiV. A neoadjuvant (HTa) based on liposomes and cholera toxin combined with CpG\/Alum was exploited and evaluated in mice. The neoadjuvant group showed a more protective efficacy than the CpG\/Alum group. The aforementioned results indicated that the subunit vaccine could be used as a promising candidate vaccine for preventing Nipah virus infection.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2022.1031523","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T09:24:43Z","timestamp":1665048283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Assessment of the immunogenicity and protection of a Nipah virus soluble G vaccine candidate in mice and pigs"],"prefix":"10.3389","volume":"13","author":[{"given":"Zihan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"10652","DOI":"10.1073\/pnas.0504887102","article-title":"Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus","volume":"102","author":"Bonaparte","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"146ra107","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African Green monkeys from Nipah virus challenge","volume":"4","author":"Bossart","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.apsb.2017.08.003","article-title":"In vivoEstablishment of pseudovirus infection mouse models for pharmacodynamics evaluation of filovirus entry inhibitors","volume":"8","author":"Chen","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.288.5470.1432","article-title":"Nipah virus: a recently emergent deadly paramyxovirus","volume":"288","author":"Chua","year":"2000","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Dan","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41541-021-00284-w","article-title":"A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus","volume":"6","author":"Geisbert","year":"2021","journal-title":"npj Vaccines."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1128\/jvi.78.2.834-840.2004","article-title":"Nipah virus: vaccination and passive protection studies in a hamster model","volume":"78","author":"Guillaume","year":"2004","journal-title":"J. Virol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo","volume":"164","author":"Hartmann","year":"2000","journal-title":"J. Immunol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/v13101942","article-title":"Combinatorial F-G immunogens as Nipah and respiratory syncytial virus vaccine candidates","volume":"13","author":"Isaacs","year":"2021","journal-title":"Viruses"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.4269\/ajtmh.2011.10-0567","article-title":"Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission","volume":"85","author":"Kim","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.virol.2012.06.001","article-title":"Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs","volume":"432","author":"Kong","year":"2012","journal-title":"Virology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1089\/0882824041310612","article-title":"Innate immune responses in respiratory syncytial virus infections","volume":"17","author":"Krishnan","year":"2004","journal-title":"Viral Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/cti.2015.13","article-title":"Granzyme B mediated function of parvovirus B19-specific CD4(+) T cells","volume":"4","author":"Kumar","year":"2015","journal-title":"Clin. Trans. immunol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/jmv.27596","article-title":"Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift","volume":"94","author":"Li","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/v12040480","article-title":"Fc-based recombinant Henipavirus vaccines elicit broad neutralizing antibody responses in mice","volume":"12","author":"Li","year":"2020","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/jmv.24345","article-title":"Origin and evolution of Nipah virus","volume":"88","author":"Lo Presti","year":"2016","journal-title":"J. Med. Virol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3201\/eid1508.081237","article-title":"Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007","volume":"15","author":"Luby","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1128\/CMR.9.4.532","article-title":"Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases","volume":"9","author":"Lucey","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e1002836","DOI":"10.1371\/journal.ppat.1002836","article-title":"Cedar virus: a novel Henipavirus isolated from Australian bats","volume":"8","author":"Marsh","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1016\/j.vaccine.2008.05.016","article-title":"A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats","volume":"26","author":"MCea Chern","year":"2008","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fvets.2019.00016","article-title":"Vaccine development for Nipah virus infection in pigs","volume":"6","author":"McLean","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"100384","DOI":"10.1016\/j.onehlt.2022.100384","article-title":"The pig as an amplifying host for new and emerging zoonotic viruses","volume":"14","author":"McLean","year":"2022","journal-title":"One Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nature03838","article-title":"EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus","volume":"436","author":"Negrete","year":"2005","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","article-title":"Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities","volume":"8","author":"Nie","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1038\/srep42769","article-title":"Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system","volume":"7","author":"Nie","year":"2017","journal-title":"Sci. Rep."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.20506\/rst.19.1.1202","article-title":"Nipah virus infection of pigs in peninsular Malaysia","volume":"19","author":"Nor","year":"2000","journal-title":"Rev. Sci. Tech."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1743-422X-10-237","article-title":"Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months","volume":"10","author":"Pallister","year":"2013","journal-title":"Virol. J."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1086\/315457","article-title":"Case-control study of risk factors for human infection with a new zoonotic paramyxovirus","volume":"181","author":"Parashar","year":"2000","journal-title":"Nipah J. Infect. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1016\/j.vaccine.2016.08.028","article-title":"Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response","volume":"34","author":"Pickering","year":"2016","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3390\/vaccines10071004","article-title":"Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African Green monkeys from Nipah virus disease","volume":"10","author":"Prescott","year":"2015","journal-title":"Other"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1016\/j.vaccine.2015.12.075","article-title":"Status of vaccine research and development of vaccines for Nipah virus","volume":"34","author":"Satterfield","year":"2016","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/ana.21178","article-title":"Long-term neurological and functional outcome in Nipah virus infection","volume":"62","author":"Sejvar","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"108549","DOI":"10.1016\/j.vetmic.2019.108549","article-title":"Immune responses in mice and pigs after Oral vaccination with rabies virus vectored Nipah disease vaccines","volume":"241","author":"Shuai","year":"2019","journal-title":"Vet. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/01652176.2019.1580827","article-title":"Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies \u2013 a comprehensive review","volume":"39","author":"Singh","year":"2019","journal-title":"Vet. Q."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-021-00729-3","article-title":"A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions","volume":"28","author":"Tseng","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nri.2017.118","article-title":"TH2 cell development and function","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1128\/JVI.00263-06","article-title":"Recombinant Nipah virus vaccines protect pigs against challenge","volume":"80","author":"Weingartl","year":"2006","journal-title":"J. Virol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/imm.12688","article-title":"Distinct T helper cell dependence of memory B-cell proliferation versus plasma cell differentiation","volume":"150","author":"Zabel","year":"2017","journal-title":"Immunology"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0008403","DOI":"10.1371\/journal.pntd.0008403","article-title":"IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability","volume":"15","author":"Zhang","year":"2021","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1031523\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T09:24:48Z","timestamp":1665048288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1031523\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":40,"alternative-id":["10.3389\/fmicb.2022.1031523"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1031523","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"1031523"}}